Full text

Turn on search term navigation

© 2017. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Introduction: To assess progress towards the UNAIDS 90–90–90 initiative targets, we examined the HIV care cascade in the population‐based Rakai Community Cohort Study (RCCS) in rural Uganda and examined differences between sub‐groups.

Methods: Self‐reports and clinical records were used to assess the proportion achieving each stage in the cascade. Statistical inference based on a χ2 test for categorical variables and modified Poisson regression were used to estimate prevalence risk ratios (PRRs) and 95% confidence intervals (CI) for enrolment into care and initiating antiretroviral therapy (ART).

Results: From September 2013 through December 2015, 3,666 HIV‐positive participants were identified in the RCCS. As of December 2015, 98% had received HIV Counseling and Testing (HCT), 74% were enrolled in HIV care, and 63% had initiated ART of whom 92% were virally suppressed after 12 months on ART. Engagement in care was lower among men than women (enrolment in care: adjPRR 0.84, 95% CI 0.77–0.91; ART initiation: adjPRR 0.75, 95% CI 0.69–0.82), persons aged 15–24 compared to those aged 30–39 (enrolment: adjPRR 0.72, 95% CI 0.63–0.82; ART: adjPRR 0.69, 95%CI 0.60–0.80), unmarried persons (enrolment: adjPRR 0.84, 95% CI 0.71–0.99; ART adjPRR 0.80, 95% CI 0.66–0.95), and new in‐migrants (enrolment: adjPRR 0.75, 95% CI 0.67–0.83; ART: adjPRR 0.76, 95% CI 0.67–0.85). This cohort achieved 98–65–92 towards the UNAIDS “90–90–90” targets with an estimated 58% of the entire HIV‐positive RCCS population virally suppressed.

Conclusions: This cohort achieved over 90% in both HCT and viral suppression among ART users, but only 65% in initiating ART, likely due to both an ART eligibility criterion of <500 CD4 cells/mL and suboptimal entry into care among men, younger individuals, and in‐migrants. Interventions are needed to promote enrolment in HIV care, particular for hard‐to‐reach sub‐populations.

Details

Title
Human immunodeficiency virus care cascade among sub‐populations in Rakai, Uganda: an observational study
Author
Billioux, Veena G 1 ; Chang, Larry W 2 ; Reynolds, Steven J 3 ; Nakigozi, Gertrude 4 ; Ssekasanvu, Joseph 5 ; Grabowski, Mary K 5 ; Ssekubugu, Robert 4 ; Nalugoda, Fred 4 ; Godfrey Kigozi 4 ; Kagaayi, Joseph 4 ; Serwadda, David 6 ; Gray, Ronald H 5 ; Wawer, Maria J 5 

 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA 
 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA 
 Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA 
 Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda 
 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda 
 Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda; Department of Disease Control & Environmental Health, School of Public Health, Makerere University, Kampala, Uganda 
Section
Research Article
Publication year
2017
Publication date
2017
Publisher
John Wiley & Sons, Inc.
e-ISSN
1758-2652
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2290321602
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.